The Cancer Drugs Fund in Practice and Under the New Framework.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2019 AND VI 37 AND IP 7
Results: 13
1
2
Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".
- Published in:
- 2019
- By:
- Publication type:
- Letter
3
A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective.
- Published in:
- 2019
- By:
- Publication type:
- journal article
4
Response to 'Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States"'.
- Published in:
- 2019
- By:
- Publication type:
- Letter
5
Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
6
Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholds of Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
7
Correction to: Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
8
Correction to: Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
9
Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
10
The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
11
Correction to: Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?
- Published in:
- 2019
- By:
- Publication type:
- corrected article
12
Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
13
Autologous Chondrocyte Implantation with Chondrosphere for Treating Articular Cartilage Defects in the Knee: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article